Alger Life Sciences Innovation Offshore Fund, LP — Form D
Alger Life Sciences Innovation Offshore Fund, LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-01-03. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-01-03
- Form: D
- Accession: 0002005494-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Minimum investment: $500K
- Security types: fund interests
- SEC file number: 021-501378
Issuer
- Name: Alger Life Sciences Innovation Offshore Fund, LP
- CIK: 0002005494
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2023
- Address: 100 PEARL STREET 27TH FLOOR, NEW YORK, NY, 10004
- Phone: 212-806-8800
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Hal Cayley Liebes | Executive Officer | New York, NY |
| Daniel Cayley Chung | Executive Officer | New York, NY |
| Daniel Cayley Chung | Related Person | New York, NY |
| Robert Louis Kincel | Executive Officer | New York, NY |
| Robert Louis Kincel | Related Person | New York, NY |
| N/A Fred Alger Management, LLC | Promoter | New York, NY |
| N/A Alger Alternative Holdings II, LLC | Promoter | New York, NY |
| Hal Liebes | Related Person | New York, NY |
Other filings by this issuer (3)
More